ClinicalTrials.Veeva

Menu

Blood Indices of Systemic Inflammation in Critically Ill Patients With Abdominal Sepsis

A

Assiut University

Status

Not yet enrolling

Conditions

Critically Ill
Abdominal Sepsis

Treatments

Diagnostic Test: Complete blood count

Study type

Observational

Funder types

Other

Identifiers

NCT06095830
Abdominal sepsis in ICU

Details and patient eligibility

About

This study aims to clarify the role of blood indices of systemic inflammation in ICU-admitted patients with abdominal sepsis to assess their diagnostic significance as well as their prognostic value.

Full description

Sepsis is a complex, multifactorial syndrome which can evolve into conditions of varying severity. If left untreated, it may lead to the functional impairment of one or more vital organs or systems. Severity of illness and the inherent mortality risk escalate from sepsis, through severe sepsis (defined as sepsis associated with at least one acute organ dysfunction, hypoperfusion, or hypotension) and septic shock up multi-organ failure. Previous studies have demonstrated that mortality rates increase dramatically in the event of severe sepsis and septic shock.

Abdominal infection is a common indication for admission to the intensive care unit (ICU) and the abdomen is the second most common site of invasive infection among critically ill patients in epidemiological and therapeutic studies. Abdominal infections are more often associated with septic shock and acute kidney injury than are infections in other sites. The spectrum of disease and severity is broad and management of these infections is challenging.

The inflammatory response in patients with sepsis depends on the causative pathogen and the host (genetic characteristics and coexisting illnesses), with differential responses at local, regional, and systemic levels.

On the systemic level, several indices have been used as a mirror to outcome in patients with various pathologies, of which are the Blood Indices of Systemic Inflammation.

As these blood indices are easy and available investigation that may be promising predictors in sepsis, we aim in this study to evaluate their role in abdominal sepsis.

Enrollment

120 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Patients above the age of 18 years old.
  2. Patients fulfilling the Systemic Inflammatory Response Syndrome (SIRS) criteria.
  3. Patients with an established diagnosis of abdominal sepsis, clinically and by investigations.

Exclusion criteria

  1. Patients below the age of 18 years.
  2. Patients with haematological disorders.
  3. Patients with concomitant severe morbidity affecting the prognosis other than sepsis e.g. hypovolemic shock, brainstem infarction, pulmonary embolism, etc.

Trial design

120 participants in 3 patient groups

Group 1
Description:
Patients that recovered from sepsis without complications
Treatment:
Diagnostic Test: Complete blood count
Group 2
Description:
Patients that didn't recover from sepsis. Further subdivided into: Group 2-A: developed complications Group 2-B: non-surviving
Treatment:
Diagnostic Test: Complete blood count
Group 3
Description:
Control group of healthy individuals
Treatment:
Diagnostic Test: Complete blood count

Trial contacts and locations

1

Loading...

Central trial contact

Mohammed K. Abdellah, Bachelor

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems